Share-Based Compensation - Stock Options Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands |
9 Months Ended |
|
Oct. 31, 2020
USD ($)
$ / shares
shares
|
|---|
| Number of Shares |
|
| Outstanding at beginning of period (in shares) | shares |
3,650
|
| Granted (in shares) | shares |
0
|
| Exercised (in shares) | shares |
0
|
| Forfeited or expired (in shares) | shares |
(307)
|
| Outstanding at end of period (in shares) | shares |
3,343
|
| Expected to vest at end of period (in shares) | shares |
2,028
|
| Exercisable at end of period (in shares) | shares |
1,270
|
| Grant Date Weighted Average Exercise Price Per Share |
|
| Outstanding at beginning of period (in USD per share) | $ / shares |
$ 7.67
|
| Granted (in USD per share) | $ / shares |
0
|
| Exercised (in USD per share) | $ / shares |
0
|
| Forfeited or expired (in USD per share) | $ / shares |
18.21
|
| Outstanding at end of period (in USD per share) | $ / shares |
6.71
|
| Expected to vest at end of period (in USD per share) | $ / shares |
2.70
|
| Exercisable at end of period (in USD per share) | $ / shares |
$ 13.25
|
| Weighted-Average Remaining Contractual Life (in years) |
|
| Outstanding at end of period |
7 years 2 months 12 days
|
| Expected to vest at end of period |
8 years 8 months 12 days
|
| Exercisable at end of period |
4 years 9 months 18 days
|
| Aggregate Intrinsic Value |
|
| Outstanding at end of period | $ |
$ 0
|
| Expected to vest at end of period | $ |
0
|
| Exercisable at end of period | $ |
$ 0
|